Literature DB >> 32147628

Discovering drugs to treat coronavirus disease 2019 (COVID-19).

Liying Dong1, Shasha Hu2, Jianjun Gao1.   

Abstract

The SARS-CoV-2 virus emerged in December 2019 and then spread rapidly worldwide, particularly to China, Japan, and South Korea. Scientists are endeavoring to find antivirals specific to the virus. Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19) in China; some promising results have been achieved thus far. This article summarizes agents with potential efficacy against SARS-CoV-2.

Entities:  

Keywords:  2019-nCoV; COVID-19; SARS-CoV-2; novel coronavirus; pneumonia

Mesh：

Substances：

Year:  2020        PMID： 32147628     DOI： 10.5582/ddt.2020.01012

Source DB:  PubMed          Journal:  Drug Discov Ther        ISSN： 1881-7831


  381 in total

1.  Development of vaccines and antivirals for combating viral pandemics.

Authors:  Norbert Pardi; Drew Weissman
Journal:  Nat Biomed Eng       Date:  2020-12       Impact factor: 25.671

Review 2.  Covid-19: The Biggest Threat of the 21st Century: In Respectful Memory of the Warriors All Over the World.

Authors:  Oğuz Karcıoğlu; Aycan Yüksel; Ayşe Baha; Aslıhan Banu Er; Dorina Esendağlı; Pınar Yıldız Gülhan; Selen Karaoğlanoğlu; Merve Erçelik; İrem Şerifoğlu; Ethem Yıldız; Nurdan Köktürk
Journal:  Turk Thorac J       Date:  2020-11-01

Review 3.  Evidence and speculations: vaccines and therapeutic options for COVID-19 pandemic.

Authors:  Rabeea Siddique; Qian Bai; Muhammad Adnan Shereen; Ghulam Nabi; Guang Han; Farooq Rashid; Saeed Ahmed; Aigerim Benzhanova; Mengzhou Xue; Suliman Khan
Journal:  Hum Vaccin Immunother       Date:  2020-10-16       Impact factor: 3.452

4.  Clinical value analysis of IgM and IgG antibodies detected by nucleic acid in patients with COVID-19.

Authors:  Tao Ding; Nengping Zhang
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

5.  Anti-tuberculosis (TB) chemotherapy dynamically rescues Th1 and CD8+ T effector levels in Han Chinese pulmonary TB patients.

Authors:  Guobao Li; Fang Yang; Xing He; Zhi Liu; Jiang Pi; Yuzhen Zhu; Xue Ke; Shuyan Liu; Min Ou; Huixin Guo; Zhuoran Zhang; Gucheng Zeng; Guoliang Zhang
Journal:  Microbes Infect       Date:  2019-11-01       Impact factor: 2.700

6.  Chronic myeloid leukaemia and the use of tyrosine kinase inhibitors in the days of COVID-19 pandemic.

Authors:  Ahmet Emre Eşkazan
Journal:  Br J Clin Pharmacol       Date:  2020-05-20       Impact factor: 4.335

7.  Is the anti-filarial drug diethylcarbamazine useful to treat COVID-19?

Authors:  Anuruddha Abeygunasekera; Saroj Jayasinghe
Journal:  Med Hypotheses       Date:  2020-05-18       Impact factor: 1.538

8.  Retrospective analysis of the effect of current clinical medications and clinicopathological factors on viral shedding in COVID-19 patients.

Authors:  Yanfeng Pan; Qingqing Li; Xue Yu; Qiankun Luo; Tao Qin; Ningbo Xin; Qian Zhang; Xianyang Li; Xinwei Du; Qingxia Zhao; Li Sun
Journal:  Biomed Rep       Date:  2020-10-20

9.  SARS-CoV-2 and rhinovirus/enterovirus co-infection in a critically ill young adult patient in Colombia

Authors:  Juan Pablo Orozco-Hernández; Juan José Montoya-Martínez; Manuel Conrado Pacheco-Gallego; Mauricio Céspedes-Roncancio; Gloria Liliana Porras-Hurtado
Journal:  Biomedica       Date:  2020-10-30       Impact factor: 0.935

Review 10.  The COVID-19 pandemic: Clinical practice advice for gastroenterologists, hepatologists, and liver transplant specialists.

Authors:  Gökhan Kabaçam; Murat Dayangaç; Enver Üçbilek; Cemal Nuri Erçin; Fulya Günsar; Murat Akyıldız; Mesut Akarsu; Mehmet Demir; Sabahattin Kaymakoğlu; Zeki Karasu; Ramazan İdilman
Journal:  Turk J Gastroenterol       Date:  2020-05       Impact factor: 1.852
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.